van 't Veer LJ - Search Results

1

ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population.

Broeks A, de Klein A, Floore AN, Muijtjens M, Kleijer WJ, Jaspers NG, van 't Veer LJ. Broeks A, et al. Hum Mutat. 1998;12(5):330-7. doi: 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H. Hum Mutat. 1998. PMID: 9792409

2

A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.

van Dijk MA, Floore AN, Kloppenborg KI, van 't Veer LJ. van Dijk MA, et al. Cancer Res. 1997 Aug 15;57(16):3478-85. Cancer Res. 1997. PMID: 9270016

3

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE, van 't Veer LJ. Broeks A, et al. Am J Hum Genet. 2000 Feb;66(2):494-500. doi: 10.1086/302746. Am J Hum Genet. 2000. PMID: 10677309 Free PMC article.

4

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

Broeks A, Russell NS, Floore AN, Urbanus JH, Dahler EC, van T Veer MB, Hagenbeek A, Noordijk EM, Crommelin MA, van Leeuwen FE, van T Veer LJ. Broeks A, et al. Int J Radiat Biol. 2000 May;76(5):693-8. doi: 10.1080/095530000138367. Int J Radiat Biol. 2000. PMID: 10866292

5

[From gene to disease; ataxia telangiectasia].

Broeks A, van 't Veer LJ, Ottenheim C, Hiel JA, Kleijer WJ, Weemaes C. Broeks A, et al. Ned Tijdschr Geneeskd. 2003 Mar 1;147(9):386-9. Ned Tijdschr Geneeskd. 2003. PMID: 12661456 Review. Dutch.

6

IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.

Broeks A, Urbanus JH, de Knijff P, Devilee P, Nicke M, Klöpper K, Dörk T, Floore AN, van't Veer LJ. Broeks A, et al. Hum Mutat. 2003 May;21(5):521-8. doi: 10.1002/humu.10204. Hum Mutat. 2003. PMID: 12673794

7

Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?

Szabo CI, Schutte M, Broeks A, Houwing-Duistermaat JJ, Thorstenson YR, Durocher F, Oldenburg RA, Wasielewski M, Odefrey F, Thompson D, Floore AN, Kraan J, Klijn JG, van den Ouweland AM, Wagner TM, Devilee P, Simard J, van 't Veer LJ, Goldgar DE, Meijers-Heijboer H. Szabo CI, et al. Cancer Res. 2004 Feb 1;64(3):840-3. doi: 10.1158/0008-5472.can-03-2678. Cancer Res. 2004. PMID: 14871810

8

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

Broeks A, de Witte L, Nooijen A, Huseinovic A, Klijn JG, van Leeuwen FE, Russell NS, van't Veer LJ. Broeks A, et al. Breast Cancer Res Treat. 2004 Jan;83(1):91-3. doi: 10.1023/B:BREA.0000010697.49896.03. Breast Cancer Res Treat. 2004. PMID: 14997059

9

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

Michalides R, Griekspoor A, Balkenende A, Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L, Neefjes J. Michalides R, et al. Cancer Cell. 2004 Jun;5(6):597-605. doi: 10.1016/j.ccr.2004.05.016. Cancer Cell. 2004. PMID: 15193262 Free article.

10

Late-onset common cancers in a kindred with an Arg213Gln TP53 germline mutation.

Ruijs MW, Verhoef S, Wigbout G, Pruntel R, Floore AN, de Jong D, van T Veer LJ, Menko FH. Ruijs MW, et al. Fam Cancer. 2006;5(2):169-74. doi: 10.1007/s10689-005-4789-9. Fam Cancer. 2006. PMID: 16736287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page